Navigation Links
IOF-ESCEO congress will focus on advances in the management of musculoskeletal diseases
Date:1/14/2014

With the ageing of the population, health authorities all over the world are expecting a dramatic increase in the number of people suffering from chronic diseases of bone, muscle and joints. The IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases has become an important educational and research forum to help physicians meet the growing challenge posed by these serious diseases.

Held annually in Europe, the Congress is jointly organized by the International Osteoporosis Foundation (IOF) and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). In 2014 the Congress will take place from April 2-5 in Seville, Spain.

Delegates will include leading researchers and health professionals from a broad spectrum of specializations, including rheumatology, endocrinology, orthopedics, radiology, general practice, and rehabilitation. CME accreditation is expected (application in process).

Accepted abstracts (submission possible until January 16, 2014) will be published in 'Osteoporosis International', one of the field's most highly cited peer-reviewed journals. Delegates who submit abstracts may be eligible for scholarships and awards: further information is available at http://www.wco-iof-esceo.org/awards


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
41-229-940-100
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Hot topics in translational bone research at IOF-ESCEO 3rd Pre-Clinical Symposium
2. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
3. Purdue professor to speak before Congress about nanotechnology in brain treatment research
4. ESMO 2012 Congress: A path for medical oncology innovations
5. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
6. International congress on behavior, animal husbandry and animal well-being in Vienna
7. 2016 International Congress of Entomology to be held in Orlando, Florida
8. Madidi conservationist wins award at World Conservation Congress
9. Noteworthy studies at the ESMO 2012 Congress
10. Majority of Americans doubt Congress and White House can avoid fiscal cliff
11. European Congress on Osteoporosis and Osteoarthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2017)... ARLINGTON, Va. , June 30, 2017 /PRNewswire-USNewswire/ ... a leading developer and supplier of face and ... the ATA Featured Product provider program. ... created an innovative way to monitor a driver,s ... benefit greatly from being able to detect fatigue ...
(Date:5/23/2017)... May 23, 2017  Hunova, the first robotic gym for the rehabilitation ... officially launched in Genoa, Italy . The first 30 ... and the USA . The technology was developed and ... by the IIT spin-off Movendo Technology thanks to a 10 million euro ... Release, please click: ...
(Date:5/6/2017)... 5, 2017 RAM Group , ... new breakthrough in biometric authentication based on a ... properties to perform biometric authentication. These new sensors are ... created by Ram Group and its partners. This sensor ... supply chains and security. Ram Group is a ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... The ... three Winners and six Finalists of the 2017 Blavatnik Regional Awards for Young ... Family Foundation and administered by the New York Academy of Sciences to honor ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first-ever genomics analysis platform specifically designed for life science researchers to analyze ... pioneering researcher Rosalind Franklin, who made a major contribution to the discovery ...
(Date:10/11/2017)... ... October 11, 2017 , ... Proscia Inc ... hosting a Webinar titled, “Pathology is going digital. Is your lab ready?” with ... adoption best practices and how Proscia improves lab economics and realizes an increase ...
(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
Breaking Biology Technology: